Comparative study of azithromycin and amoxicillin/clavulanic acid in the treatment of lower respiratory tract infections

European Journal of Clinical Microbiology & Infectious Diseases

Volumn 10, Issue 5, 1991, Pages 437-439

  Balmes, P ^a   Clerc, G ^b   Dupont, B ^c   Labram, C ^d   Pariente, R ^e   Poirier, R ^d  

^a NÎMES UNIVERSITY HOSPITAL   (France)

^b Centre Hospitalier Specialise   (France)

^c Service des Vaccinations   (France)

^d CENTRE HOSPITALIER   (France)

^e BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; CLAVULANIC ACID;

ADULT; ARTICLE; BRONCHITIS; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMOXICILLIN; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTIBIOTICS, COMBINED; AZITHROMYCIN; BRONCHITIS; CLAVULANIC ACIDS; COMPARATIVE STUDY; DRUG ADMINISTRATION SCHEDULE; ERYTHROMYCIN; FEMALE; HUMAN; MALE; MIDDLE AGE; PNEUMONIA; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS PNEUMONIAE;

EID: 0025773855     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/BF01968024     Document Type: Article

References (4)

1. Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-aza-9a homoerythromycin A derivatives: a new class of macrolides, the azalides
2. Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms
3. Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution
4. The pharmacokinetics of azithromycin in human serum and tissues